Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

There is growing interest in utilizing pharmacogenetic (PGx) testing to guide antidepressant use, but there is lack of clarity on how to implement testing into clinical practice. We administered two surveys at 17 sites that had implemented or were in the process of implementing PGx testing for antid...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuteja, Sony, Salloum, Ramzi G., Elchynski, Amanda L., Smith, D. Max, Rowe, Elizabeth, Blake, Kathryn V., Limdi, Nita A., Aquilante, Christina L., Bates, Jill, Beitelshees, Amber L., Cipriani, Amber, Duong, Benjamin Q., Empey, Philip E., Formea, Christine M., Hicks, J. Kevin, Mroz, Pawel, Oslin, David, Pasternak, Amy L., Petry, Natasha, Ramsey, Laura B., Schlichte, Allyson, Swain, Sandra M., Ward, Kristen M., Wiisanen, Kristin, Skaar, Todd C., Van Driest, Sara L., Cavallari, Larisa H., Bishop, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841452/
https://www.ncbi.nlm.nih.gov/pubmed/34562070
http://dx.doi.org/10.1111/cts.13154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841452/
https://www.ncbi.nlm.nih.gov/pubmed/34562070
http://dx.doi.org/10.1111/cts.13154

Ejemplares similares